Akeso Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Saint Petersburg Russian Federation (2008)

Organization Overview

First Clinical Trial
2017
NCT03261011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Akeso | Akesobio Australia Pty Ltd | Akeso Pharmaceuticals, Inc. | Akeso Tiancheng, Inc